February 9, 2026 · Form 4 insider transaction
O'Kane Kieran sold 1,527 shares of BIODESIX INC at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.; These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.; These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.